| Fosfomycin Tromethamine |
For Suspension |
|
|
Develop a dissolution method |
|
|
2017/07/20 |
| Fosinopril Sodium |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Fosinopril Sodium/Hydrochlorothiazide |
Tablet |
|
|
Refer to USP |
|
|
2008/08/11 |
| Fostemsavir Tromethamine |
Tablet (Extended Release |
I
(Basket) |
100 |
0.05 M Phosphate Buffer, pH 6.8
buffer, pH 6.8 |
1000 |
1, 2, 3, 5, 7, 10, 12, 16, 20 and 24 hours |
2021/08/19 |
| Frovatriptan succinate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Fruquintinib |
Capsule |
II (Paddle) with sinker |
75 |
Phosphate-buffered saline (PBS), pH 6.8, w/ 0.08% SLS |
900 |
5, 10, 15, 20, 30, 45 and 60 |
2025/09/08 |
| Furosemide |
Tablet |
|
|
Refer to USP |
|
|
2010/08/05 |
| Futibatinib |
Tablet |
II (Paddle) |
50 |
50 mM phosphate dihydrogen phosphate buffer, pH 6.8 with 0.5% Tween 80 |
900 |
5, 10, 15, 30, 45, 60 and 75 |
2023/11/30 |
| Gabapentin |
Tablet |
I (Basket) |
100 |
Modified simulated gastric fluid (SGF) |
900 |
1, 2, 4, 6, 8, 10, 12, 14 and 16 hours |
2023/11/30 |
| Gabapentin |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Gabapentin |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Gabapentin Enacarbil |
Tablet (Extended Release) |
II (Paddle) |
50 |
10 mM Phosphate buffer at pH 7.4 with 1.0 % SLS |
500 (for 300 mg); 900 (for 600 mg) |
0.5, 1, 2, 4, 6, 8, 12 and 24 hours |
2013/01/31 |
| Galantamine HBr |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Galantamine HBr |
Capsule (Extended Release) |
II (Paddle) |
50 |
50 mM potassium dihydrogen phosphate buffer pH 6.5 |
900 |
1, 4, 10 and 12 hours |
2006/01/20 |
| Ganaxolone |
Suspension |
II (Paddle) |
25 |
2.8% SDS |
900 |
2.5, 5, 7.5, 10, 15, 20 and 30 |
2023/11/30 |
| Ganciclovir |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Gefitinib |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Gemfibrozil |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |
| Gemifloxacin Mesylate |
Tablet |
II (Paddle) |
50 |
0.01 N HCl |
900 |
10, 20, 30 and 45 |
2007/01/03 |
| Gepirone Hydrochloride |
Tablet, Extended Release |
II (Paddle) |
50 |
0.01 N HCl |
900 |
1, 2, 4, 8, 10, 12, 14, 16, 18 and 20 hours |
2025/06/23 |